Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Vitragan MAA accepted for review

Jan. 13, 2006

PR Pharmaceuticals and OSI collaborate on sustained-release Macugen

Jan. 13, 2006

iDESTRIN relieves signs and symptoms of dry eye syndrome in postmenopausal women

Jan. 10, 2006

Phase II trial for NT-501 in dry AMD

Jan. 9, 2006

InSite Vision completes debt refinancing to support AzaSite development and filing

Jan. 4, 2006

Genentech submits BLA for Lucentis in wet AMD

Jan. 2, 2006

New beta-adrenoceptor antagonists for eye disorders reported by Othera

Dec. 29, 2005

Animal study begins for Acusolin for cataracts

Dec. 29, 2005

Prostanoid EP4 agonists for ocular disorders emerge from Merck Frosst R&D

Dec. 21, 2005

European CHMP to issue updated positive opinion for Macugen

Dec. 19, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...